| News

Welcome to the Basel region: Cerdia

30.04.2019

Cerdia’s history starts with Rhodia Acetow more than 100 years ago: The company was founded in 1912 in the Rhone valley in France. Its specialty were polyester and nylon textiles. Later, Rhodia Acetow developed huge business opportunities in producing cigarette filter tow and cellulose acetate. In 2018, the company opened a new chapter in their books: The international headquarters were moved from Freiburg i.B., Germany to Basel. The new stand-alone entity in Basel was rebranded Cerdia in March 2019. Today, Cerdia has an annual turnover of more than 600 million Swiss francs. 1300 employees work for the company with hubs in France, Singapore, the US, Brazil and Russia.

Philippe Rosier, CEO Cerdia (img: Pino Covino)

From tow to timber

The acetate specialists are well-known for their innovative products such as filter tow for IQOS cigarettes, filter tow for super slim cigarettes, coloured or biodegradable tow. While global cigarette consumption is in decline, the application range for acetylation is not: Cerdia promotes a durable timber range under the name Accoya, licensed from the British Accsys Group: Wood acetylation alters the timber, making it more durable and reducing its ability to absorb water by approximately 80 percent. The processed wood is safe from rot, mould and fungi, yet bendable, non-toxic and 100 percent recyclable, making it applicable for façades as well as window frames or outdoor furniture.

Make Cerdia more international

The new positioning reflects the transformation of the company, says Philippe Rosier, CEO of Cerdia: “We chose Basel for our new corporate headquarters to transform the culture of the company from here and make Cerdia more international.” The company set up their management offices in a carefully renovated town house in Basel. Philippe Rosier: “The BaselArea.swiss team did a great job finding this wonderful location and supported us with the administrative part of the transition.” Basel not only offers Cerdia proximity to tobacco companies in Switzerland and a spot within the community of global pharma companies, but also access to the vast network of architectural firms that are settled in the area – optimal for developing the market for Accoya timber.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

VectivBio secures investments totaling 110 million dollars
Basel Area Business & Innovation, Innovation, Invest

VectivBio secures investments totaling 110 million dollars

The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars from both new and existing...

Read More
Polyphor receives up to 18 million dollars for development of antibiotics
Basel Area Business & Innovation, Innovation, Invest

Polyphor receives up to 18 million dollars for development of antibiotics

The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X to combat antimicrobial resistance. Polyphor...

Read More
What makes Switzerland’s economy resilient in face of COVID pandemic
Basel Area Business & Innovation, Invest

What makes Switzerland’s economy resilient in face of COVID pandemic

The COVID-19 pandemic has hit economies worldwide – and we have not yet overcome it. However, Switzerland is among the...

Read More
DayOne Accelerator applications open
Basel Area Business & Innovation, Innovation

DayOne Accelerator applications open

We are excited to announce the opening of the call for the DayOne Accelerator, now in its 3rd year!

Read More
Matériaux Sabag printing concrete elements
Basel Area Business & Innovation, Innovation, Invest

Matériaux Sabag printing concrete elements

The Jura-based company Matériaux Sabag is now using a 3D printing solution to produce its concrete elements. This approach allows...

Read More
Six companies win the i4Challenge
Basel Area Business & Innovation, Innovation

Six companies win the i4Challenge

The i4Challenge expert jury has selected six winners from 18 finalists. The Industry 4.0 solutions range from 3D printing, IoT,...

Read More
Monte Rosa Therapeutics banks 96 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Monte Rosa Therapeutics banks 96 million US dollars

The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US dollars after closing a successful...

Read More
Roche launches new coronavirus antibody test
Basel Area Business & Innovation, Innovation, Invest

Roche launches new coronavirus antibody test

Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development...

Read More
Investors see great potential in Polyneuron
Basel Area Business & Innovation, Innovation, Invest

Investors see great potential in Polyneuron

The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million...

Read More
Lonza set to manufacture coronavirus drug for Humanigen
Basel Area Business & Innovation, Innovation, Invest

Lonza set to manufacture coronavirus drug for Humanigen

The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...

Read More
1 2 3 21

Do you have a question? We'd like to hear from you.